Company Overview
- Headquarters
- 6005 Hidden Valley Road, Suite 110, Carlsbad CA
- Website
- designtx.com
- Phone
- (858) 293-4900
- Employees
- 48
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$50B
Who is Design Therapeutics
Design Therapeutics is a clinical-stage biotechnology company headquartered in Carlsbad, California. The company employs 48 people and generates approximately $50 million in annual revenue. Design Therapeutics focuses on developing a novel class of therapies known as GeneTAC™ gene targeted chimera small molecules. These molecules are engineered to modulate the expression of specific disease-causing genes, aiming to treat the root cause of various genetic disorders. The company's lead therapeutic program targets Friedreich ataxia, with additional programs underway for Fuchs endothelial corneal dystrophy and myotonic dystrophy type-1. Design Therapeutics is also actively engaged in research and development for multiple other serious degenerative disorders caused by nucleotide repeat expansions. For more information about Design Therapeutics and its innovative therapies, please visit designtx.com.
Company Leadership
Companies Similar to Design Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Design Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 50M | Cambridge, MA | |||
| 50M | 59 | Foster City, CA | ||
| 50M | 74 | San Diego, CA | ||
| 50M | 181 | New Haven, CT | 2017 | |
| 50M | 58 | Carlsbad, CA |